Provides for a feasibility study concerning a pharmaceutical and therapeutics committee for Medicaid managed care
To Prohibit Pharmaceutical Manufacturers From Restricting Or Limiting Prescription Medications To A Limited Distribution Network Of Out-of-state Pharmacies.
An Act Concerning The Department Of Social Services' Recommended Changes To The Medical Assistance And Pharmacy Statutes.
Provides for the Medicaid Pharmaceutical and Therapeutics Committee.
Prohibits the La. Medicaid Program from providing coverage for brand name drugs in certain instances (OR DECREASE SG RV See Note)
Provides relative to prescription drug benefits of certain managed care organizations participating in the La. Medicaid coordinated care network program (RE1 INCREASE GF EX See Note)
AN ACT relating to the Medicaid program and declaring an emergency.
Urging The Governor To Ensure That Relevant State Agencies, Including The Department Of Health And Department Of Human Services, Collaborate To Explore Avenues To Ensure Continued Access To Affordable Medications For The State's Underserved Populations Under The 340b Drug Pricing Program And Urging Hawaii's Congressional Delegation And Relevant Federal Agencies To Monitor Pharmaceutical Companies And Take Appropriate Actions To Protect The Integrity Of The 340b Drug Pricing Program.